In late 1917 I had a painful swelling at the soft palate, it soon receeded after I lit up a cigar. It is now 1923 and I have an ulcerous or leukoplastic growth on my jaw and palate. Just now, on April 7 1923 Felix Deutsch does not agree with epithelioma and talks about a “bad leukoplakia”. He seems distressed after having seen the ulcer. A rhinologist will perform the surgery. Based on the anamnesis so far, is this the right choice of action?

·

·

Dear Mr. Sigmund Freud,

Thank you for your inquiry regarding the ulcerous or leukoplastic growth on your jaw and palate. Based on the anamnesis provided, it is understandable that you are seeking clarity on the appropriate course of action.

The presence of a painful swelling in the soft palate that receded upon resuming smoking, as occurred in 1917, may have been misleading in terms of its etiology. It is not uncommon for patients to attribute symptomatic relief to unrelated interventions. However, the recurrence of symptoms in the form of ulceration in 1923 is a significant finding that warrants thorough investigation.

Dr. Felix Deutsch’s opinion of “bad leukoplakia” suggests a concern for a potentially pre-malignant condition. Leukoplakia can indeed be a precursor to more serious conditions such as squamous cell carcinoma. It is important to note that leukoplakia can present with varying degrees of dysplasia, and in some cases, it may already represent an early form of cancer.

Given the potential gravity of the situation, a biopsy is an essential diagnostic step to determine the nature of the lesion. This would typically involve the removal of a small section of the affected tissue, which is then examined under a microscope by a pathologist. The biopsy can provide a definitive diagnosis and guide the treatment plan.

If the lesion is confirmed to be an epithelioma (a term historically used to describe a carcinoma), the standard treatment would involve surgical excision with clear margins to ensure complete removal of the malignant cells. Depending on the extent of the lesion, this could be a complex procedure, potentially requiring reconstruction of the affected area.

Given that a rhinologist is set to perform the surgery, it is crucial that they have experience in managing oral neoplasms. In cases of oral cancer, a multidisciplinary approach is often beneficial, involving oral and maxillofacial surgeons, otolaryngologists, oncologists, and other specialists as needed.

Alternative treatments may include radiation therapy or chemotherapy, particularly if the lesion is found to be malignant and depending on the stage of the disease. These treatments can be used as adjuncts to surgery or, in some cases, as primary treatment modalities.

It is also important to address any modifiable risk factors, such as tobacco use. Smoking cessation is strongly advised, as continued tobacco use can exacerbate the condition and hinder treatment outcomes.

In summary, the right choice of action at this juncture would be to obtain a definitive diagnosis through a biopsy and then proceed with the most appropriate treatment based on the pathology results. Collaboration with a team of specialists experienced in the management of oral neoplasms is recommended to ensure the best possible care.

Please do not hesitate to reach out for further discussion or to arrange a consultation.

Sincerely,

Prof. Dr. R. E.
Oral and Maxillofacial Surgeon

2024-01-30 21:11 Telekonsultation

Dear Professor Freud,

Based on the anamnesis you have provided, it is indeed concerning that you have experienced a painful swelling in the soft palate in 1917, which receded after resuming smoking, and now present with an ulcerous or leukoplastic growth on your jaw and palate. The initial self-resolution of symptoms may have been coincidental rather than causative, and the current presentation warrants thorough investigation.

The differential diagnosis for such lesions includes a range of possibilities from benign leukoplakia to malignant epithelioma. Leukoplakia itself is a clinical term that describes a white patch or plaque that cannot be characterized as any other condition; it is often considered a precancerous lesion. Epithelioma, on the other hand, is a term historically used to describe a carcinoma of the epithelial tissue, which could be indicative of a more serious pathology such as squamous cell carcinoma.

Given the potential gravity of the situation, it is imperative to have a definitive diagnosis established through a biopsy. A rhinologist, while skilled in the anatomy of the nasal cavity and related structures, may not be the most appropriate specialist to perform surgery on a lesion that could potentially be malignant. An oral and maxillofacial surgeon or a head and neck surgeon would typically be more specialized in the management of oral cavity lesions, including performing biopsies and subsequent surgical interventions if necessary.

In the current year of 1923, the standard of care would involve a biopsy to obtain a histopathological diagnosis. If the lesion were to be diagnosed as malignant, the treatment would likely involve surgical excision with clear margins to ensure complete removal of the cancerous tissue. This could be followed by reconstruction and rehabilitation, which may include the use of an obturator prosthesis if there is significant tissue loss.

If we were to consider the advancements in medicine and treatment modalities available in 2024, the approach to diagnosis and management might include more sophisticated imaging techniques such as MRI or PET scans to assess the extent of the lesion. Additionally, molecular profiling of the tumor could potentially guide targeted therapy. Photodynamic therapy and laser surgery are also modern treatments that could be considered for certain types of oral lesions. Moreover, immunotherapy has emerged as a promising treatment for various cancers, including head and neck cancers.

In conclusion, while Dr. Felix Deutsch’s opinion is valuable, I would strongly recommend a consultation with an oral and maxillofacial surgeon for a biopsy and comprehensive treatment plan. The urgency of addressing this lesion is underscored by its potential to be a malignant growth, and prompt, specialized intervention is crucial.

Sincerely,

Hans Pichler (1877 – 1949)
Head of the Maxillofacial Surgery Department
First Surgical University Clinic

Termin vereinbaren

Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien

Telefon 01 408 95 00 66
Email ordination@smile.wien

Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.

© 2023 Eurodoc Telemedizin ForschungsgesellschaftmbH

Dr. Michael Truppe


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.